Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate for prevention of postoperative cognitive disorders after CABG
IRCT20260728070394N1Phase 3Completed
- Sponsor
- Isfahan University of Medical Sciences
- Start
- Jul 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, single-blind trial of magnesium sulfate in post-operative cognitive decline (POCD) and delirium (2 arms), sponsored by Isfahan University of Medical Sciences. Primary endpoint: Incidence of postoperative cognitive dysfunction. Started Jul 2026; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
post-operative cognitive decline (POCD)delirium
Beyond the preview
Go deeper on IRCT20260728070394N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260728070394N1.